| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.4% stake in Archer Aviation Inc. |
| 07/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 10.2% stake in Vuzix Corporation |
| 07/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 10.5% stake in Quantum-Si Inc. |
| 06/09/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 10.3% stake in UiPath, Inc. |
| 06/09/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 10.1% stake in Roku, Inc. |
| 05/09/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 10.4% stake in Markforged Holding Corp. |
| 03/22/2023 |
SC 13G
| ARK Investment Management LLC reports a 39.4% stake in ARK Venture Fund |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G
| ARK Investment Management LLC reports a 7.1% stake in Verve Therapeutics, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.6% stake in Veracyte, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 9.4% stake in UiPath, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.8% stake in Twist Bioscience Corporation |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.7% stake in Teladoc Health, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 9.2% stake in Surface Oncology, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 9.9% stake in Roku, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 5.8% stake in Repare Therapeutics Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 9.9% stake in Quantum-Si Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 12% stake in Personalis, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.2% stake in PagerDuty, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.4% stake in Pacific Biosciences of California, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 6.6% stake in MATERIALISE NV |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 8.2% stake in Markforged Holding Corp. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 6.2% stake in Kratos Defense & Security Solutions Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.2% stake in Invitae Corporation |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.2% stake in Intellia Therapeutics, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 10.7% stake in Ginkgo Bioworks Holdings, Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 9% stake in Exact Sciences Corp. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 5.6% stake in DraftKings Inc. |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 10% stake in CRISPR Therapeutics AG |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|